Cargando…

Molecular Analysis of Elements of Melanoma Insensitivity to TCR-Engineered Adoptive Cell Therapy

Metastatic melanoma accounts for the highest number of skin cancer-related deaths. Traditional treatments are ineffective due to their inability to induce tumor regression at a high rate. Newer treatments such as immune checkpoint inhibitors (ICI), targeted therapy (BRAFi and MEKi), and T cell recep...

Descripción completa

Detalles Bibliográficos
Autor principal:	Jazirehi, Ali R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8584081/ https://www.ncbi.nlm.nih.gov/pubmed/34769156 http://dx.doi.org/10.3390/ijms222111726

Ejemplares similares

T cell receptor (TCR)-transgenic CD8 lymphocytes rendered insensitive to transforming growth factor beta (TGFβ) signaling mediate superior tumor regression in an animal model of adoptive cell therapy
por: Quatromoni, Jon G, et al.
Publicado: (2012)

Engineering Strategies to Enhance TCR-Based Adoptive T Cell Therapy
por: Rath, Jan A., et al.
Publicado: (2020)

Trial Watch: Adoptive TCR-Engineered T-Cell Immunotherapy for Acute Myeloid Leukemia
por: Campillo-Davo, Diana, et al.
Publicado: (2021)

TCR-engineered adoptive cell therapy effectively treats intracranial murine glioblastoma
por: Schaettler, Maximilian O, et al.
Publicado: (2023)

Reversal of Resistance in Targeted Therapy of Metastatic Melanoma: Lessons Learned from Vemurafenib (BRAF(V600E)-Specific Inhibitor)
por: Torres-Collado, Antoni Xavier, et al.
Publicado: (2018)

Characterization of Postinfusion Phenotypic Differences in Fresh Versus Cryopreserved TCR Engineered Adoptive Cell Therapy Products
por: Nowicki, Theodore S., et al.
Publicado: (2018)

TCR-Directed Therapy in the Treatment of Metastatic Uveal Melanoma
por: Strobel, Sophia B., et al.
Publicado: (2022)

Adoptive Cellular Therapy for Multiple Myeloma Using CAR- and TCR-Transgenic T Cells: Response and Resistance
por: Füchsl, Franziska, et al.
Publicado: (2022)

TCR-NK Cells: A Novel Source for Adoptive Immunotherapy of Cancer
por: Karahan, Zeynep Sena, et al.
Publicado: (2023)

Evolution of CD8(+) T Cell Receptor (TCR) Engineered Therapies for the Treatment of Cancer
por: Sun, Yimo, et al.
Publicado: (2021)

TCR engineered T cells for solid tumor immunotherapy
por: Zhang, Yikai, et al.
Publicado: (2022)

Generation of TCRα-transduced T cells for adoptive transfer therapy of salmonellosis in mice
por: Kalinina, Anastasiia, et al.
Publicado: (2021)

Immune correlates of melanoma survival in adoptive cell therapy
por: Lee, Agnes Fermin, et al.
Publicado: (2013)

The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering
por: Shevyrev, D. V., et al.
Publicado: (2022)

Tumor-Resident Dendritic Cells and Macrophages Modulate the Accumulation of TCR-Engineered T Cells in Melanoma
por: Hotblack, Alastair, et al.
Publicado: (2018)

Optimizing engineered TCR T cell therapy for synovial sarcoma
por: D'Angelo, Sandra, et al.
Publicado: (2015)

Gene Augmentation and Editing to Improve TCR Engineered T Cell Therapy against Solid Tumors
por: Lo Presti, Vania, et al.
Publicado: (2020)

Adoptive Cell Therapy of Melanoma with Cytokine-induced Killer Cells
por: Kim, Ji Sung, et al.
Publicado: (2015)

Adoptive Cell Therapy for Patients with Melanoma
por: Dudley, Mark E.
Publicado: (2011)

The Quest for the Best: How TCR Affinity, Avidity, and Functional Avidity Affect TCR-Engineered T-Cell Antitumor Responses
por: Campillo-Davo, Diana, et al.
Publicado: (2020)

Emerging Strategies in TCR-Engineered T Cells
por: Wei, Fang, et al.
Publicado: (2022)

Cancer Therapy With TCR-Engineered T Cells: Current Strategies, Challenges, and Prospects
por: Shafer, Paul, et al.
Publicado: (2022)

TCR-engineered T cell therapy in solid tumors: State of the art and perspectives
por: Baulu, Estelle, et al.
Publicado: (2023)

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
por: Pang, Zhi, et al.
Publicado: (2023)

Adoptive NK Cell Therapy: A Promising Treatment Prospect for Metastatic Melanoma
por: van Vliet, Amanda A., et al.
Publicado: (2021)

TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy
por: Tvingsholm, Siri Amanda, et al.
Publicado: (2023)

“First AID” for T cell adoptive transfer: TCR affinity maturation by somatic hypermutation
por: Gozlan, Yosi M, et al.
Publicado: (2013)

Engineered T Cells for the Adoptive Therapy of B-Cell Chronic Lymphocytic Leukaemia
por: Koehler, Philipp, et al.
Publicado: (2012)

TCR-Engineered, Customized, Antitumor T Cells for Cancer Immunotherapy: Advantages and Limitations
por: Chhabra, Arvind
Publicado: (2011)

TCR repertoire characteristics predict clinical response to adoptive CTL therapy against nasopharyngeal carcinoma
por: Wang, Guoping, et al.
Publicado: (2021)

Overcoming Resistance of Human Non-Hodgkin’s Lymphoma to CD19-CAR CTL Therapy by Celecoxib and Histone Deacetylase Inhibitors
por: Torres-Collado, Antoni Xavier, et al.
Publicado: (2018)

Genetically engineered lymphocytes in metastatic melanoma: TIL 1383I TCR transduced T-cells are detectable after infusion
por: Regan, Courtney, et al.
Publicado: (2013)

Focus on Adoptive T Cell Transfer Trials in Melanoma
por: Hershkovitz, Liat, et al.
Publicado: (2010)

Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies
por: Schober, Kilian, et al.
Publicado: (2020)

Process Development for Adoptive Cell Therapy in Academia: A Pipeline for Clinical-Scale Manufacturing of Multiple TCR-T Cell Products
por: Silva, Daniela Nascimento, et al.
Publicado: (2022)

Breaking Bottlenecks for the TCR Therapy of Cancer
por: Gaissmaier, Lena, et al.
Publicado: (2020)

Blocking TCR restimulation induced necroptosis in adoptively transferred T cells improves tumor control
por: Kesarwani, Pravin, et al.
Publicado: (2016)

TCR-engineered T cells: A model of inducible TCR expression to dissect the interrelationship between two TCRs
por: Reuß, Simone, et al.
Publicado: (2014)

S76. Adoptive cell therapy of melanoma with autologous tumour infiltrating lymphocytes
por: Svane, I, et al.
Publicado: (2014)

Adoptive T-cell therapy for Leukemia
por: Garber, Haven R, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_o1st4r0d5aobmvpgvk4a4e0jfv